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Background: Pancreatitis-induced splenic vein thrombosis (PISVT) is an acquired anatomic abnormality
that impacts decision making in pancreatic surgery. Despite this influence, its incidence and the rate of
associated gastrointestinal (GI) bleeding are imprecisely known.
Methods: The MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials and Cochrane Database
of Systematic Reviews databases were searched from their inception to June 2010 for abstracts docu-
menting PISVT in acute (AP) or chronic pancreatitis (CP). Two reviewers independently graded abstracts
for inclusion in this review. Heterogeneity in combining data was assumed prior to pooling. Random-
effects meta-analyses were performed to estimate percentages and 95% confidence intervals.
Results: After review of 241 abstracts, 47 studies and 52 case reports were graded as relevant. These
represent a cohort of 805 patients with PISVT reported in the literature. A meta-analysis of studies
meeting inclusion criteria shows mean incidences of PISVT of 14.1% in all patients, 22.6% in patients with
AP and 12.4% in patients with CP. The incidence of associated splenomegaly was only 51.9% in these
patients. Varices were identified in 53.0% of patients and were gastric in 77.3% of cases. The overall rate
of GI bleeding was 12.3%.
Conclusions: Although reported incidences of PISVT vary widely across studies, an overall incidence of
14.1% is reported. Splenomegaly is an unreliable sign of PISVT. Although the true natural history of PISVT
remains unknown, the collective reported rate of associated GI bleeding is 12.3%.
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Introduction
Pancreatitis-induced splenic vein thrombosis (PISVT) is an
acquired disorder that occurs as a sequel to both acute (AP) and
chronic pancreatitis (CP). Although as many as 37 different
specific aetiologies for splenic vein thrombosis (SVT) have been
reported,1 the majority are related to diseases of the pancreas.2
Although PISVT has an historical association with neoplasms,3
recent data incriminate AP and CP as its principal causes.4–8
Regardless of its aetiology, SVT generates a localized form of
portal hypertension commonly referred to as ‘sinistral’, ‘left-sided’
or ‘linear’. Collateral blood flow develops through the splenoportal
or gastroepiploic systems and the resulting localized venous
hypertension may produce gastric, oesophageal or colonic varices.
This paper is based on a presentation given at the 11th Annual Meeting of
the American Hepato-Pancreato-Biliary Association, 10–13 March 2011,
Miami, Florida.
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These varices are a potential source of significant gastrointestinal
(GI) bleeding (Figs 1 and 2).9,10 In relation to operative manage-
ment, it has been suggested that patients with PISVT and a prior
history of upper GI tract bleeding or symptomatic hypersplenism
may represent a high-risk subgroup in whom the risk : benefit
profile is altered in favour of splenectomy.11–13 By contrast, patients
in a small cohort without this history of bleeding, in whom PISVT
was identified through imaging, were found to have an incidence
of bleeding of only 3.8% (two of 53 patients) over a median
follow-up of 34 months.14
Although PISVT is an important anatomic abnormality that
impacts operative decision making in pancreatic surgery, no con-
sensus has been reached on either its incidence in patients with
pancreatitis or the rate of associated GI bleeding.1 The aim of this
study was to conduct a systematic review of the published litera-
ture on PISVT, with appropriate filters and controls, to determine
both its incidence and the rate of associated GI tract bleeding.
Materials and methods
Data sources
The MEDLINE, EMBASE, Cochrane Database of Systematic
Reviews (CDSR) and Cochrane Central Register of Clinical Trials
(CCRCT) databases were searched from their inception up to and
including June 2010. Search terms were used in both isolation and
combination to identify all published evidence. Reference lists
from identified review articles and published studies were queried
to identify articles not found through our initial database search.
Data extraction
Two investigators (JRB and TJH) independently reviewed the
titles and abstracts of all returned references regardless of lan-
guage or publication status to identify studies for inclusion in the
analysis. All identified articles were examined using a predesigned
proforma and the data collected were entered into a database for
analysis. A list of gathered data is detailed in Table 1. The meth-
odological quality of studies was assessed for a minimum Oxford
Centre for Evidence-Based Medicine (CEBM) level of 2B.15 When
appropriate, studies were allocated to separate quantitative
cohorts for independent meta-analyses of variables. Results of
studies yielding a heterogeneous dataset of isolated and non-
isolated PISVT were corrected for if results were reported in a
manner that allowed the exclusion of outcomes specific for an
isolated PISVT patient cohort. An analogous process was rarely
employable for datasets confounded by malignancy. References
reporting datasets with incomplete or inconsistent isolation of a
non-confounded PISVT cohort were excluded (Table 2). A sche-
matic diagram depicting reference flow through the systematic
review process is shown in Fig. 3.
Statistical analysis
All included references were assigned to appropriate cohorts for
individual meta-analyses of variables. A schematic diagram
depicting the flow of references through the quantitative arm of
this study is shown in Fig. 4.When combining data from the trials,
we assumed the presence of heterogeneity existed prior to pooling
and used the random effects model developed by DerSimonian.16
This model allows for adjustment for variability between trials by
providing a more conservative estimate of the range of an effect.
Individualized random effects meta-analyses were performed to
estimate percentages and 95% confidence intervals (CIs) for all
endpoints queried.
Figure 1 Normal venous anatomy. Arrows indicate the directional
flow of venous blood. CV, coronary vein; PV, portal vein; RGV, right
gastric vein; SV, splenic vein; GEV, gastroepiploic vein; SMV, supe-
rior mesenteric vein; IMV, inferior mesenteric vein
Figure 2 Splenic vein thrombosis causing left-sided portal hyperten-
sion. Note the gastric varices, dilatation of short gastric, gastroepi-
ploic (GEV) and coronary (CV) veins. The portal vein (PV), superior
mesenteric vein (SMV) and inferior mesenteric vein (IMV) are patent.
RGV, right gastric vein; SV, splenic vein
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Results
In the initial search, a total of 241 articles were retrieved; nine
additional unique references were found through a review of ref-
erence lists. After duplicates had been removed and the exclusion
criteria noted in Table 2 applied, 47 clinical studies and 52 case
reports were graded as relevant; these referred to a cohort of
805 distinct patients with PISVT. Thirty-eight references
were assessed as eligible for quantitative inclusion by the
reviewers.2,3,6,7,9,11–14,17–45 The median CEBM level of included
studies was 2A.15 A meta-analysis of contemporary studies
meeting inclusion criteria showed an overall mean reported inci-
dence of PISVT of 14.1% (Figure 5).11,13,17,25–29,36 Mean incidences
varied from 22.6% in patients with AP to 12.4% in patients with
CP. The incidence of associated splenomegaly was only
51.9%.3,6,7,9,11,13,18,19,24,26,28,36,42,46 Overall, 53.0% of patients in this
cohort were found to have varices, 77.3% of which were gastric.
The aggregate rate of associated GI bleeding in this series was
12.3% (Figure 6).11,13,14,17,20,21,27,29 All reported rates with associ-
ated 95% CIs are shown in Table 3.
Discussion
Thrombosis and occlusion of the splenic vein following inflam-
mation of the pancreas are principally related to location
(Figs 1and 2). The consequence of this altered venous anatomy is
isolated hypertensive short gastric veins that can develop into
varices in the gastric fundus submucosa. These ‘isolated gastric
varices’, without evidence of oesophageal varices, represent the
sine qua non of SVT. Although it has been postulated that sple-
nomegaly might also be a consistent finding in all patients with
SVT,47 explicit studies of splenomegaly in SVT report actual inci-
dences in the range of 42–54%.42,48 The 51.9% incidence of sple-
nomegaly in patients in this collective review supports these
observations. This lack of consistent compensatory hyper-
splenism makes the diagnosis of SVT dependent on imaging
either the obstructed splenic vein directly or the associated gastro-
oesophageal varices. To this end, contrast-enhanced computed
tomography (CT) or direct endoscopic examination [oesophago-
gastroduodenoscopy (OGD)] are the modalities most widely used
to identify SVT.29 In this study, oesophagogastric varices were
identified in only 53.0% of patients with PISVT and 77.3% of
these cases involved isolated gastric varices. These troubling
inconsistencies in accurately identifying the hallmark sequelae of
PISVT can be at least partially explained by the heterogeneity
Table 1 Data collected according to the proforma for articles to be
included in this review of reported cases of pancreatitis-induced
splenic vein thrombosis (PISVT)
Incidence of reported PISVT
Isolated splenic vein thrombosis identified, n
Pancreatitis patients studied, n
Diagnostic medium of splenic vein thrombosis
Type of pancreatitis
Incidence of bleed
Patients with documented gastrointestinal bleed, n
Patients with isolated PISVT, n
Incidence of varices
Varices, n/patients with isolated PISVT, n
Gastric varix
Oesophageal varix
Gastro-oesophageal varix
Varix diagnostic media
Computed tomography-diagnosed varices bleed rate
Oesophagogastroduodenoscopy-diagnosed varix bleed rate
Incidence of PISVT-associated gastrointestinal bleeding
Splenomegaly
Patients demonstrating splenomegaly, n
Patients with isolated PISVT, n
Patients with PISVT–splenomegaly with bleed, n
Splenectomy cohort bleed in follow-up
Non-splenectomy cohort bleed in follow-up
Mean follow-up in patients involved
Type of study
Table 2 Exclusion criteria and numbers of papers excluded by these
criteria
CEBM evidence level < 2B, n = 6a
Studies enrolling fewer than six patients, n = 2
Dataset previously published, n = 4
Failure to identify isolated PISVT cohort, n = 41
Failure to identify pancreatitis, n = 10
Confounding presence of malignancy, n = 13
Confounding presence of cirrhosis, n = 5
Data derived from animal model, n = 2
Data limited to post-splenectomy outcomes, n = 18
Data derived from autopsy alone, n = 2
Inconsistent radiologic analysis for PISVT, n = 10
Irrelevant title with no abstract, n = 9
Unacceptable publication format, n = 5
Article irretrievable, n = 4
References meeting global exclusion criteria, n = 130b
Exclusion criteria for individual meta-analyses
Data pre-1995 with unreliable PISVT identification strategy
Mean follow-up time of <3 months
Data not limited to identified acute pancreatitis patients
Data not limited to identified chronic pancreatitis patients
aAfter removing case reports and references meeting other exclusion
criteria.
bAfter removing duplicates and case reports.
CEBM, Oxford Centre for Evidence-Based Medicine; PISVT, pancreatitis-
induced splenic vein thrombosis.
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across studies of the imaging techniques used to identify varices
(CT vs. venous portography vs. upper GI endoscopy). Although
OGD is the reference standard for the diagnosis of gastro-
oesophageal varices, adherence to an optimal technique is impor-
tant in maximizing its sensitivity.49 Perri and colleagues50
prospectively studied 102 patients with liver disease in a screening
programme using OGD and multi-detector CT scans of the
abdomen. In this study, CT had sensitivity of 90% and specificity
of 50% for diagnosing oesophageal varices and sensitivity of 87%
for the detection of gastric varices. In addition, CT identified a
significant number of gastric varices, peri-oesophageal varices and
extra-luminal pathology that were important for establishing
optimal patient care. These authors concluded that contrast-
enhanced CT appeared to be a reasonable screening tool for the
identification of varices relative to the reference standard OGD.50
Another possible explanation for the lack of isolated gastric
varices in PISVT is the variation in coronary vein drainage
described by Little and Moossa.9 Coronary veins in up to 17% of
the patients studied by these authors were found to drain directly
into the splenic vein rather than the portal vein. In these patients,
adequate venous decompression of splenoportal venous hyper-
tension is established through gastro-oesophageal collaterals
(oesophageal varices). Although the current results support the
notion that the most common pathway to venous decompression
is through isolated gastric varices, this review also identified
gastro-oesophageal varices in patients with SVT at ranges that
support the observations of Little and Moossa.9
Lastly, further confounding the interpretation of many studies
in this field is the failure of investigators to isolate PISVT from
confounding variables such as hepatic cirrhosis or generalized
portal hypertension. This lack of precision was the main reason
why 41 reports (17%) were excluded from this analysis. It is well
established that a third of cirrhosis patients with documented
oesophageal varices will bleed within 2 years of diagnosis and that
the mortality rate in the first episode of upper GI haemorrhage is
20–35% despite aggressive management.49,51 Although the inci-
dence and severity of GI bleeding from isolated SVT with sinistral
portal hypertension remain poorly defined, it is clear that neither
is of the magnitude reported in patients with hepatic cirrhosis and
generalized portal hypertension.
All forms of pancreatitis have been implicated as risk factors for
SVT. Targeted studies report its incidence in hereditary pancreati-
tis,31 autoimmune pancreatitis,52,53 AP and CP.11,13,14,32 Splenic vein
thrombosis is most commonly associated with CP, although a
single attack of AP appears sufficient to cause this disorder.5,9,54 It
is possible that the current data on AP may overestimate the
incidence of SVT in patients with AP as a result of selection bias
towards a higher severity in reported studies. Unfortunately, the
severity of AP was inconsistently indexed in most studies. More-
over, debate continues on whether or not the severity of pancre-
atitis has any bearing on the incidence of SVT.9,29,38 Individual
studies have incriminated high peak serum amylase levels, pan-
creatic pseudocyst, splenomegaly, documented right upper quad-
rant varices and the decision to manage complications in AP
operatively as correlated to higher rates of PISVT.7,13,32
In either AP or CP, the incidence of splenic vein abnormalities
has ranged from 0.9% to 54% in surgical series35,55 and up to 89%
in radiographic series.56 Complete venous occlusion has been
most widely studied in the context of CP, with reported rates
ranging from 1.5% to 41.6% in surgical series28,55 and from 4.5%
to 45% in radiographic series.18,57 Historically, patients with SVT
most commonly presented clinically with an episode of GI bleed-
ing or abdominal pain.3 With improvement in both the availabil-
ity and quality of cross-sectional imaging, the majority of patients
with SVT are currently diagnosed while they are asymptom-
atic.11,13,14,58 Despite this trend towards increasing asymptomatic
diagnosis, the literature may retain an overall sampling bias
towards symptomatic PISVT; it is for this reason that the current
meta-analysis was limited to post-1995 data. For example,
between 1969 and 1984, 45% of patients reported with PISVT
initially presented with GI bleeding.7 Similarly, removing the limit
on study age in the literature included in this analysis yields an
overall PISVT incidence of 14.1% (22.6% in AP and 12.4% in CP)
and a bleed rate of 19.0%.2,3,6,7,9,11–14,17–45 A comparison of these
data with results reported in the current review indicates both an
References identified in
primary search
References retrieved for detailed
evaluation
References excluded
References excluded
References involved in quantitative
synthesis
Duplicates = 17
Irretrievable = 4
Abstracts meeting
global exclusion
criteria = 121
MEDLINE = 144
MEDLINE = 67
EMBASE = 89
EMBASE = 22
Cochrane CRCT = 7
Cochrane CRCT = 0
Cochrane DSR = 1
Cochrane DSR = 1
Additional references = 9
MEDLINE = 22
EMBASE = 4
Cochrane CRCT = 0
Cochrane DSR = 1
Additional references = 9
Case reports = 52
References meeting
global exclusion 
criteria = 9
n = 99
n = 38
n = 241
n = 142
n = 61
Figure 3 Flow of references through the systematic review.
Cochrane CRCT, Cochrane Central Register of Clinical Trials;
Cochrane DSR, Cochrane Database of Systematic Reviews
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increasing awareness of PISVT and a decreasing concern for GI
bleed in the era of universal cross-sectional imaging.
In summary, despite the heterogeneity of available data, this
systematic analysis is the first study to attempt to quantify the
incidence and rate of associated GI bleeding in patients with
PISVT. Reported incidences of PISVT were found to vary widely
among individual studies, but an overall incidence of 14.1% was
reported. Splenomegaly was found to be an unreliable sign of
PISVT. Although the true natural history of PISVT remains con-
troversial, the collective reported rate of associated GI bleeding
was 12.3%. Although routine prophylactic splenectomy at the
time of pancreatic surgery in patients with PISVT has been rec-
ommended by some authors, these relatively low rates of reported
GI bleeding seem to support the safety of observational manage-
ment in asymptomatic patients.
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